Ritonavir is recommended for use in combination with other protease inhibitors as a pharmacological booster in the prevention and treatment of HIV/AIDS, and not as an antiretroviral in its own right.
EML status history
Therapeutic equivalent for
Antiretrovirals > Protease inhibitors
- Oral > Liquid: 400 mg per 5 mL
- Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable)
- Oral > Other: 100 mg powder